Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulants for PVST Prevention After Splenectomy in Cirrhosis
NCT04397289Phase 2Completed
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Feb 2018
- Primary completion
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rivaroxaban, heparin, warfarin in portal vein thrombosis (PVT), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Started Feb 2018; status: completed.
02
Drugs
rivaroxabanheparinwarfarin
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT04397289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04397289.